Aromatase inhibitors: structural features and biochemical characterization. - Wikidata - awgldk - TriplyDB

Aromatase inhibitors: structural features and biochemical characterization.

Aromatase inhibitors: structural features and biochemical characterization.

http://www.wikidata.org/entity/Q36721768

about

Prevention and treatment of bone fragility in cancer patient Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro.Inflammatory osteoarthritis which was precipitated by Arimidex and resolved with tamoxifen.Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: structure-function studies and inhibitor development.New experimental models for aromatase inhibitor resistance.Cotargeting of CYP-19 (aromatase) and emerging, pivotal signalling pathways in metastatic breast cancer.Synthesis and Biological Evaluation of Amidinourea and Triazine Congeners as Inhibitors of MDA-MB-231 Human Breast Cancer Cell Proliferation.The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.7-Meth-oxy-2-phenyl-chroman-4-one CYP19A1 gene polymorphism and colorectal cancer etiology in Saudi population: case-control study.Letrozole usage adjuvant to gonadotropins for ovulation induction for patients with clomiphene citrate failure.Treatment of aromatase (CYP19A1) inhibitor reduces fertility in porcine sperm.Effects of different doses of letrozole on the incidence of early-onset ovarian hyperstimulation syndrome after oocyte retrieval.Comparison of the effects of letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome.

P2860

Q26775765-832B240D-0B1E-4CDC-9347-0EBCCD2730BE Q33586637-2E430912-E761-4EBC-B4E6-61E863C51582 Q34536015-10624A1D-4D6F-4331-885C-ABDF5A8B8F9F Q34561176-AE80AD49-8CC0-4B8C-BBA6-A47F61F9543A Q36870346-8220F210-4AB4-46AB-A8CD-774681A2DC98 Q37570653-129245B5-6B96-463F-8EEC-72FF74DC415C Q38721894-CB6A8E10-4FB0-4D52-ABED-375EA55EFAD1 Q38851505-48D4B392-3499-4919-81BB-000FE519172B Q42234853-379D1E3A-7AFD-409D-98C5-AA7016AD10AA Q42736011-C7671E52-3E26-40EF-BE62-B68CB0A60C03 Q46638885-25C7B8B1-60FB-4CF9-9807-45F4C6373A89 Q48586519-9BF30526-1615-4BDF-8DC1-647AA37B97EA Q48594924-4A6633DA-4E1A-4DF4-BC6D-661257408EB3 Q50949601-5B18439C-597F-4D48-BC2B-364233F14C4C

P2860

Aromatase inhibitors: structural features and biochemical characterization.

http://www.wikidata.org/entity/Q36721768

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Aromatase inhibitors: structural features and biochemical characterization.

@ast

Aromatase inhibitors: structural features and biochemical characterization.

@en

type

label

Aromatase inhibitors: structural features and biochemical characterization.

@ast

Aromatase inhibitors: structural features and biochemical characterization.

@en

prefLabel

Aromatase inhibitors: structural features and biochemical characterization.

@ast

Aromatase inhibitors: structural features and biochemical characterization.

@en

P1433

Q36721768-F5A30B1E-7E61-4CAF-9A2F-442962AACF72

P1476

Q36721768-13E032F6-1015-4B99-ADEB-24B0719AEC7F

P2093

Q36721768-1C6E66B8-1D7A-4C25-BD36-66777E123A8E

Q36721768-4B9DBC6B-D4D6-48CD-A00A-94B6245F77ED

P2860

Q36721768-1A2D0BA0-6587-485C-91FC-24048DECF325

Q36721768-2AA20404-817B-4EB2-918F-C7C1C75EFFE4

Q36721768-2DEACD10-9C4F-4FA5-BDC0-692E4779DACB

Q36721768-49C2DBB4-9A74-4E10-84AC-00FFFF149079

Q36721768-6318932B-94CF-4A25-AA4A-F9D776CFD094

Q36721768-776EDC41-FBF2-4237-89D9-1C385A012E82

Q36721768-7BE04419-8A48-4E0F-B7D5-EE818876D53B

Q36721768-967D22DF-D906-4645-83D4-0EFEBD35B8D0

Q36721768-B1E1DEC9-F341-4519-A1C0-FFF692C15851

Q36721768-BFB942CD-7F17-4E49-997D-6240F43C63C0

P304

Q36721768-FE460F69-FDC2-457B-ACF9-69462292B8B0

P31

Q36721768-4CA70067-1C86-4845-A139-448487B78E4D

P356

Q36721768-709BB48E-CB53-4EEE-A99C-38A2D9470073

P407

Q36721768-E752BBE0-982F-48F3-BAB1-70928808D878

P478

Q36721768-73CBBA58-D3EF-4B1A-B114-9D61E996F2A7

P577

Q36721768-4DE022A9-8A15-4C5D-9DE9-CAA08727B0D0

P5875

Q36721768-713D71EA-23C4-4D0C-8B89-53B17867F3F1

P698

Q36721768-E5BF7E2D-C382-42BB-A51A-FF48EE7BF5B7

P356

ANNALS.1386.022

P1433

Annals of the New York Academy of Sciences

P1476

Aromatase inhibitors: structural features and biochemical characterization.

@en

P2093

Shiuan Chen

http://www.w3.org/2001/XMLSchema#string

Yanyan Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of flavonoids on aromatase activity, an in vitro study.

Flavonoid inhibition of aromatase enzyme activity in human preadipocytes.

Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase.

Aromatase inhibitors in breast cancer.

ARIMIDEX: a new oral, once-a-day aromatase inhibitor.

Structure-function studies of human aromatase.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes.

P304

237-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1196/ANNALS.1386.022

http://www.w3.org/2001/XMLSchema#string

P407

P478

1089

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6542089

http://www.w3.org/2001/XMLSchema#string

P698

17261771

http://www.w3.org/2001/XMLSchema#string